Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (3)
  • EGFR
    (3)
  • Antibacterial
    (2)
  • Antibiotic
    (2)
  • Antibody-Drug Conjugates (ADCs)
    (2)
  • Akt
    (1)
  • Antifection
    (1)
  • Antifungal
    (1)
  • Autophagy
    (1)
  • Others
    (4)
TargetMol | Tags By Application
  • ELISA
    (5)
  • Functional assay
    (5)
  • FACS
    (3)
  • FCM
    (2)
TargetMol | Tags By Natures
  • Tagetes
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (5)
  • Infection
    (2)
  • Immune System
    (1)
  • Inflammation
    (1)
Filter
Search Result
Results for "

patu

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    14
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    5
    TargetMol | Inhibitory_Antibodies
  • Natural Products
    6
    TargetMol | Natural_Products
  • ADC/ADC Related
    2
    TargetMol | All_Pathways
  • PATU
    PrAdaThiourea, N-Propyladamantylthiourea
    T2830225444-85-3
    PATU is a viricide.
    • $1,520
    6-8 weeks
    Size
    QTY
  • PATULIN
    Expansin, Claviform, Clavacin
    T3936149-29-1
    Patulin (Claviform) is a mycotoxin produced by a variety of molds commonly found in rotting apples, including Aspergillus and Penicillium.
    • $56
    In Stock
    Size
    QTY
  • Mapatumumab
    HGS-ETR1, HGSETR1, HGS-1012, HGS1012, Anti-Human TNFRSF10A Recombinant Antibody
    T77371658052-09-6
    Mapatumumab (HGS-ETR1) is a fully human agonistic monoclonal antibody targeting the TNF-related apoptosis-inducing ligand receptor 1 (TRAIL-R1). Mapatumumab exhibits anticancer activity, primarily by inducing tumor cell death through the activation of the death receptor-mediated apoptosis pathway. Mapatumumab is intended for use in cancer research.
    • $198
    In Stock
    Size
    QTY
  • Depatuxizumab
    ABT-806, ABT806
    T783261471999-69-5
    Depatuxizumab is a humanised monoclonal antibody targeting EGFR with blood-brain barrier (BBB) permeability, capable of inhibiting the growth of xenograft tumours expressing mutant EGFR vIII and wild-type EGFR. It can be conjugated with the ADC molecule Depatuxizumab mafodotin for the study of glioblastoma (GBM) and head and neck squamous cell carcinoma (SCCHN).
    • $415
    In Stock
    Size
    QTY
  • Depatuxizumab MMAE
    T82582
    Depatuxizumab MMAE is an antibody-drug conjugate (ADC) comprising the anti-EGFR monoclonal antibody depatuxizumab linked to the cytotoxic agent monomethyl auristatin E (MMAE). This ADC effectively suppresses the growth of xenograft models harboring both mutant EGFRvIII and wild-type EGFR [1].
    • Inquiry Price
    Inquiry
    Size
    QTY
  • Depatuxizumab mafodotin
    ABT-414
    T9901A-0271585973-65-4
    Depatuxizumab mafodotin, an antibody-drug conjugate (ADC) targeting the epidermal growth factor receptor (EGFR), is utilized in cancer research [1].
    • $978
    6-8 weeks
    Size
    QTY
  • Depatuxizumab MMAF
    T9901A-197
    Depatuxizumab-MMAF, an antibody-drug conjugate (ADC), comprises an EGFR-targeted antibody linked to McMMAF and is utilized in glioblastoma research.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • Isopatulin
    TN11534484-91-3
    Isopatulin can be isolated from marine-derived strains of the fungus Penicillium claviforme associated with the seagrass Zostera marina.
    • Inquiry Price
    10-14 weeks
    Size
    QTY
  • Neopatulin
    TN1157770402-10-7
    Neopatulin is an isomer involved in redox reactions and serves as a crucial biosynthetic precursor to the potent antibiotic patulin, which is produced by various fungi. It can be synthesized through a Lewis acid-catalyzed aldol condensation reaction or via the reaction of 2-formyl-1,3-dithiane with 2-(tert-butyldimethylsiloxy)-4-[(tert-butyldimethylsiloxy)methyl]furan.
    • Inquiry Price
    10-14 weeks
    Size
    QTY
  • Patulitrin
    TN474219833-25-1
    Patulitrin has antioxidant, anti-inflammatory, and larvicidal activities, oral and topical administration of patuletin and patulitrin inhibited acute inflammation in mice.
    • $870
    Inquiry
    Size
    QTY
  • Patuletin
    TN7756519-96-0
    Patuletin is a flavonol discovered in Tagetes patula that induces apoptosis in cancer cells such as CaSki, MDA-MB-231, and SK-Lu-1.
    • $247
    In Stock
    Size
    QTY
  • Epothilone B
    Patupilone, EPO 906
    T6075152044-54-7
    Epothilone B (EPO 906) is a compound isolated from the myxobacterium Sorangium cellulosum. Similar to paclitaxel, patupilone induces microtubule polymerization and stabilizes microtubules against depolymerization conditions. In addition to promoting tubulin polymerization and stabilization of microtubules, this agent is cytotoxic for cells overexpressing P-glycoprotein, a characteristic that distinguishes it from the taxanes. Patupilone may cause complete cell-cycle arrest.
    • $30
    In Stock
    Size
    QTY
  • AKT-IN-25
    T2031491619929-59-7
    AKT-IN-25 (Compound 14a) is an inhibitor of Akt that prevents the phosphorylation of Akt, thereby hindering the PI3K/Akt/mTOR signaling pathway. It arrests the cell cycle at the G1 phase, inhibits the migration of PANC-1 cells, and suppresses the proliferation of cancer cells PANC-1, PATU-T, and SUIT-2, with IC50 values of 3.05, 1.32, and 3.85 μM, respectively.
    • $1,520
    4-6 weeks
    Size
    QTY
  • Antitumor agent-165
    T210279
    Antitumor agent-165 (Compound 10l) is an effective inhibitor of focal adhesion kinase (FAK). It exhibits significant antiproliferative effects against CAPAN-1, PANC-1, PATU-T, SUIT-2, BxPC-3, PDAC-3, and PANC-1 GR cell lines, with IC50 values ranging from 1.04 to 3.44 μM.
    • Inquiry Price
    Inquiry
    Size
    QTY